|
1
|
Tick H: Nutrition and pain. Phys Med
Rehabil Clin N Am. 26:309–320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Okuse K: Pain signalling pathways: from
cytokines to ion channels. Int J Biochem Cell Biol. 39:490–496.
2007. View Article : Google Scholar
|
|
3
|
Pesquero JB, Araujo RC, Heppenstall PA,
Stucky CL, Silva JA Jr, Walther T, Oliveira SM, Pesquero JL, Paiva
AC, Calixto JB, et al: Hypoalgesia and altered inflammatory
responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci
USA. 97:8140–8145. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khasar SG, Lin YH, Martin A, Dadgar J,
McMahon T, Wang D, Hundle B, Aley KO, Isenberg W, McCarter G, et
al: A novel nociceptor signaling pathway revealed in protein kinase
C epsilon mutant mice. Neuron. 24:253–260. 1999. View Article : Google Scholar
|
|
5
|
An S, Yang J, Xia M and Goetzl EJ: Cloning
and expression of the EP2 subtype of human receptors for
prostaglandin E2. Biochem Biophys Res Commun. 197:263–270. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Numazaki M, Tominaga T, Toyooka H and
Tominaga M: Direct phosphorylation of capsaicin receptor VR1 by
protein kinase Cepsilon and identification of two target serine
residues. J Biol Chem. 277:13375–13378. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McMahon SB: NGF as a mediator of
inflammatory pain. Philos Trans R Soc Lond B Biol Sci. 351:431–440.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kidd BL and Urban LA: Mechanisms of
inflammatory pain. Br J Anaesth. 87:3–11. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Basbaum AI, Bautista DM, Scherrer G and
Julius D: Cellular and molecular mechanisms of pain. Cell.
139:267–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Scholz J and Woolf CJ: Can we conquer
pain? Nat Neurosci. 5(Suppl): 1062–1067. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schnitzer TJ: Update on guidelines for the
treatment of chronic musculoskeletal pain. Clin Rheumatol. 25(Suppl
1): S22–S29. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carter GT, Duong V, Ho S, Ngo KC, Greer CL
and Weeks DL: Side effects of commonly prescribed analgesic
medications. Phys Med Rehabil Clin N Am. 25:457–470. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cho H, Jang Y, Lee B, Chun H, Jung J, Kim
SM, Hwang SW and Oh U: Voluntary movements as a possible
non-reflexive pain assay. Mol Pain. 9:252013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Glass CK, Saijo K, Winner B, Marchetto MC
and Gage FH: Mechanisms underlying inflammation in
neurodegeneration. Cell. 140:918–934. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hofmann AS and Gross GG: Biosynthesis of
gallotannins: formation of polygalloylglucoses by enzymatic
acylation of 1,2,3,4,6-penta-O-galloylglucose. Arch Biochem
Biophys. 283:530–532. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhimani RS, Troll W, Grunberger D and
Frenkel K: Inhibition of oxidative stress in HeLa cells by
chemopreventive agents. Cancer Res. 53:4528–4533. 1993.PubMed/NCBI
|
|
17
|
Li Y, Kim J, Li J, Liu F, Liu X,
Himmeldirk K, Ren Y, Wagner TE and Chen X: Natural anti-diabetic
compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin
receptor and activates insulin-mediated glucose transport signaling
pathway. Biochem Biophys Res Commun. 336:430–437. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oh GS, Pae HO, Oh H, Hong SG, Kim IK, Chai
KY, Yun YG, Kwon TO and Chung HT: In vitro anti-proliferative
effect of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on human
hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett.
174:17–24. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heo JC, Woo SU, Kweon MA, Park JY, Lee HK,
Son M, Rho JR and Lee SH: Aqueous extract of the Helianthus annuus
seed alleviates asthmatic symptoms in vivo. Int J Mol Med.
21:57–61. 2008.
|
|
20
|
Giustarini D, Rossi R, Milzani A and
Dalle-Donne I: Nitrite and nitrate measurement by Griess reagent in
human plasma: evaluation of interferences and standardization.
Methods Enzymol. 440:361–380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Charlton E: Ethical guidelines for pain
research in humans. Committee on Ethical Issues of the
International Association for the Study of Pain. Pain. 63:277–278.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cobos EJ, Ghasemlou N, Araldi D, Segal D,
Duong K and Woolf CJ: Inflammation-induced decrease in voluntary
wheel running in mice: a nonreflexive test for evaluating
inflammatory pain and analgesia. Pain. 153:876–884. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heo JC and Lee SH: Alleviation of
asthma-related symptoms by a derivative of L-allo threonine. Int J
Mol Med. 31:881–887. 2013.PubMed/NCBI
|
|
24
|
Moncada S, Palmer RM and Higgs EA: Nitric
oxide: Physiology, pathophysiology, and pharmacology. Pharmacol
Rev. 43:109–142. 1991.PubMed/NCBI
|
|
25
|
Park KY, Lee HJ, Jeong SJ, Lee HJ, Kim HS
and Kim SH, Lim S, Kim HC, Lü J and Kim SH:
1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced
accumulation of hypoxia-inducible factor-1α and signaling in LNCaP
prostate cancer cells. Biol Pharm Bull. 33:1835–1840. 2010.
View Article : Google Scholar
|
|
26
|
Lee HJ, Jeong SJ, Lee HJ, Lee EO, Bae H,
Lieske JC and Kim SH: 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose
reduces renal crystallization and oxidative stress in a
hyperoxaluric rat model. Kidney Int. 79:538–545. 2011. View Article : Google Scholar
|
|
27
|
Lee JH, Yehl M, Ahn KS, Kim SH and Lieske
JC: 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose attenuates renal cell
migration, hyaluronan expression, and crystal adhesion. Eur J
Pharmacol. 606:32–37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pae HO, Oh GS, Jeong SO, Jeong GS, Lee BS,
Choi BM, Lee HS and Chung HT:
1,2,3,4,6-Penta-O-galloyl-beta-D-glucose up-regulates heme
oxygenase-1 expression by stimulating Nrf2 nuclear translocation in
an extracellular signal-regulated kinase-dependent manner in HepG2
cells. World J Gastroenterol. 12:214–221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang J, Li L, Kim SH, Hagerman AE and Lü
J: Anti-cancer, anti-diabetic and other pharmacologic and
biological activities of penta-galloyl-glucose. Pharm Res.
26:2066–2080. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taylor CP: Mechanisms of action of
gabapentin. Rev Neurol (Paris). 153(Suppl 1): S39–S45. 1997.
|
|
31
|
Caterina MJ, Schumacher MA, Tominaga M,
Rosen TA, Levine JD and Julius D: The capsaicin receptor: a
heat-activated ion channel in the pain pathway. Nature.
389:816–824. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rao P and Knaus EE: Evolution of
nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX)
inhibition and beyond. J Pharm Pharm Sci. 11:81s–110s. 2008.
View Article : Google Scholar
|
